I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Expert Panel consensus statements on the optimal usage of r..:
Keerthi Talari
;
Vinod Ravindran
;
Pradip Kumar
...
http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=3;spage=311;epage=321;aulast=Talari. , 2021
Link:
https://doi.org/10.4103/injr.injr_69_21
RT Journal T1
Expert Panel consensus statements on the optimal usage of rituximab for the management of rheumatoid arthritis in India
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:8afbed8558ee4037a7ddc3fa0f34c61f&Exemplar=1&LAN=DE A1 Keerthi Talari A1 Vinod Ravindran A1 Pradip Kumar A1 Pravin Patil A1 Sarath Chandra Mouli A1 Syamasis Bandyopadhyay A1 Balebail G Dharmanand A1 Abhrajit Ray A1 Shankaralingam Rajeshwari A1 Sanjiv N Amin A1 Jyotsna Oak A1 Ved Chaturvedi A1 Anand N Malaviya A1 Sukumar Mukherjee PB Wolters Kluwer Medknow Publications YR 2021 K1 b cell depletion therapy K1 biological K1 biosimilar K1 disease-modifying antirheumatic drugs K1 rheumatoid arthritis K1 rituximab K1 Diseases of the musculoskeletal system K1 RC925-935 JF http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2021;volume=16;issue=3;spage=311;epage=321;aulast=Talari LK http://dx.doi.org/https://doi.org/10.4103/injr.injr_69_21 DO https://doi.org/10.4103/injr.injr_69_21 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)